Please login to the form below

Not currently logged in
Email:
Password:

Calchan names Zahid Ali as chief scientific officer

Ali joins from Pfizer where he was a senior director

edit-calchan-zahid-aliUK-based biotech company Clachan has appointed Zahid Ali as chief scientific officer.

Calchan works with a focus on research and development of novel molecules targeting pain and imflammation, complementing Ali's two decades of industry experience and extensive knowledge of the area.

Commenting on his appointment, Ali said: “I am very excited to be joining Calchan, which has a management team of enviable experience and a very successful track record in the sector. 

“I believe the company's products have significant potential and I am looking forward to working with the team to secure Calchan's position as a leader in this field.”

Ali joins from Pfizer, where he held the position of senior director of clinical research and was responsible for a number of early clinical development programmes focused on pain research.

He began his career at Merck Sharp and Dohme Research Laboratories UK before increasing his seniority at companies including GSK, where he worked as director of discovery medicine.

Brenda Reynolds, CEO at Calchan, added: “Zahid Ali's appointment is an important one as we continue to assemble a strong team to develop our assets at Calchan. I am delighted that Zahid has chosen to join us as his considerable experience and background, notably as a Clinical Director at Pfizer, will be invaluable.”

15th May 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....

Infographics